Terms: = Colorectal cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Treatment
215 results:
1. Dasabuvir alleviates 5-fluorouracil-induced intestinal injury through anti-senescence and anti-inflammatory.
He S; Wang Z; Xia J; Jia H; Dai Q; Chen C; He F; Wang X; Zhou M
Sci Rep; 2024 Jul; 14(1):15730. PubMed ID: 38977864
[TBL] [Abstract] [Full Text] [Related]
2. Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan.
Takahashi R; Osumi H; Wakatsuki T; Yamamoto N; Taguchi S; Nakayama I; Ooki A; Ogura M; Takahari D; Chin K; Yamaguchi K; Shinozaki E
Int J Clin Oncol; 2024 Aug; 29(8):1161-1172. PubMed ID: 38819609
[TBL] [Abstract] [Full Text] [Related]
3. Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation.
Zhang D; Zhang JW; Xu H; Chen X; Gao Y; Jiang HG; Wang Y; Wu H; Yang L; Wang WB; Dai J; Xia L; Peng J; Zhou FX
Mol Cancer; 2024 Apr; 23(1):70. PubMed ID: 38576002
[TBL] [Abstract] [Full Text] [Related]
4. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
5. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the cdkn2a gene regulated TP53-PI3K/Akt signaling axis.
Chen H; Deng J; Hou TW; Shan YQ
J Ethnopharmacol; 2024 May; 325():117907. PubMed ID: 38342156
[TBL] [Abstract] [Full Text] [Related]
6. Safety, feasibility, and short-term-outcome of anal endoscopic submucosal dissection for anal intraepithelial neoplasia: an option for focal lesions?
Singhartinger F; Gantschnigg A; Holzinger J; Wagner A; Singhartinger J; Koch O; Emmanuel K; Presl J
Tech Coloproctol; 2023 Dec; 28(1):18. PubMed ID: 38102514
[TBL] [Abstract] [Full Text] [Related]
7. Integrative analysis of single-cell and bulk RNA seq to reveal the prognostic model and tumor microenvironment remodeling mechanisms of cuproptosis-related genes in colorectal cancer.
Chu B; Wang Y; Yang J; Dong B
Aging (Albany NY); 2023 Dec; 15(23):14422-14444. PubMed ID: 38078879
[TBL] [Abstract] [Full Text] [Related]
8. High expression of cdkn2a is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
[TBL] [Abstract] [Full Text] [Related]
9. Increased Incidence of Liver Metastases in colorectal
Garrett C; Cristaudo A; Barat S; Morris DL
Anticancer Res; 2023 Oct; 43(10):4657-4662. PubMed ID: 37772565
[TBL] [Abstract] [Full Text] [Related]
10. Peficitinib ameliorates 5-fluorouracil-induced intestinal damage by inhibiting aging, inflammatory factors and oxidative stress.
He S; Xia J; Jia H; Dai Q; Chen C; Zhou Y; Wang XB
Int Immunopharmacol; 2023 Oct; 123():110753. PubMed ID: 37572505
[TBL] [Abstract] [Full Text] [Related]
11. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674
[TBL] [Abstract] [Full Text] [Related]
12. PTPN9 dephosphorylates FGFR2 pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma.
Zhao L; Liu J; Li K; Zhang C; Chen T; Liu Z; Tang Y; Hu X; Shi A; Shu L; Huang S; Lian S; Zhang M; Li H; Sun J; Yu X; Zhang Z; Zhang Z; Xu Y
Hepatology; 2024 Apr; 79(4):798-812. PubMed ID: 37505213
[TBL] [Abstract] [Full Text] [Related]
13. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G; Dubinsky M; Kobayashi T; Irving PM; Howaldt S; Pokrotnieks J; Krueger K; Laskowski J; Li X; Lissoos T; Milata J; Morris N; Arora V; Milch C; Sandborn W; Sands BE;
N Engl J Med; 2023 Jun; 388(26):2444-2455. PubMed ID: 37379135
[TBL] [Abstract] [Full Text] [Related]
14. Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy.
Xia J; He S; Dai Q; Jia H; Ge Y; Zhou M; Wang X
Int Immunopharmacol; 2023 Aug; 121():110465. PubMed ID: 37336074
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive analyses of cuproptosis-related gene cdkn2a on prognosis and immunologic therapy in human tumors.
Zhang D; Wang T; Zhou Y; Zhang X
Medicine (Baltimore); 2023 Apr; 102(14):e33468. PubMed ID: 37026918
[TBL] [Abstract] [Full Text] [Related]
16. Temporal increase in the incidence of anal squamous cell carcinoma in Kentucky and factors associated with adverse outcomes.
O'brien SJ; Gaskins JT; Ellis CT; Martin BA; Mcdowell J; Gondim DD; Galandiuk S
Cancer Med; 2023 May; 12(10):11462-11474. PubMed ID: 36991580
[TBL] [Abstract] [Full Text] [Related]
17. HPV virus and biomarkers of resistance to chemoradiation in circulating tumor cells from patients with squamous cell carcinoma of the anus.
Ruano APC; de Jesus Ferreira Costa D; Braun AC; Torres JA; Barbosa PHP; Abdallah EA; Barberan C; Souza E Silva V; Bovolim G; Buim MEC; da Silva Alves V; Riechelmann RP; Chinen LTD
Pathol Res Pract; 2023 Mar; 243():154327. PubMed ID: 36731178
[TBL] [Abstract] [Full Text] [Related]
18. Cortical Parvalbumin-Positive Interneuron Development and Function Are Altered in the APC Conditional Knockout Mouse Model of Infantile and Epileptic Spasms Syndrome.
Ryner RF; Derera ID; Armbruster M; Kansara A; Sommer ME; Pirone A; Noubary F; Jacob M; Dulla CG
J Neurosci; 2023 Feb; 43(8):1422-1440. PubMed ID: 36717229
[TBL] [Abstract] [Full Text] [Related]
19. Radiomics based on preoperative rectal cancer MRI to predict the metachronous liver metastasis.
Li ZF; Kang LQ; Liu FH; Zhao M; Guo SY; Lu S; Quan S
Abdom Radiol (NY); 2023 Mar; 48(3):833-843. PubMed ID: 36529807
[TBL] [Abstract] [Full Text] [Related]
20. Targeting arf1-IQGAP1 interaction to suppress colorectal cancer metastasis and vemurafenib resistance.
Hu HF; Gao GB; He X; Li YY; Li YJ; Li B; Pan Y; Wang Y; He QY
J Adv Res; 2023 Sep; 51():135-147. PubMed ID: 36396045
[TBL] [Abstract] [Full Text] [Related]
[Next]
